期刊
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
卷 46, 期 9, 页码 4295-4301出版社
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2011.06.036
关键词
Leishmaniasis; Leishmania amazonensis; Morita-Baylis-Hillman adducts; Molecular modification strategy; Lipophilicity; Bioisoterism
资金
- CNPq
- CAPES
- FAPESQ-PB
We report the design, synthesis, in vitro evaluation against Leishmania amazonensis (IC50), cytotoxicity assays in macrophages (CC50), and selectivity index (SI=-CC50/IC50) of sixteen new congeners aromatic Morita-Baylis-Hillman adducts 1-16. The 1-16 were prepared in good to excellent yields (58%-97%) from the one pot Morita-Baylis-Hillman Reaction between the aldehydes 29-36 and the acrylates 27 or 28 under DABCO as promoter. The MBHA 2-[Hydroxy(2-nitrophenyl)propyl] propanoate (1, IC50 = 7.52 mu g/mL or 28.38 mu M; CC50 = 35.77 mu g/mL or 134.98 mu M; SI = 4.75) and 2-[Hydroxy(2-[nitrophenyl)hydroxyethyl] propanoate (9, IC50 = 5.48 mu g/mL or 20.52 mu M; CC50 = 29.81 mu g/mL or 111.64c mu M and, SI = 5.43) were the most effective and safe evaluated compounds. (C) 2011 Elsevier Masson SAS. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据